Rethinking third trimester ultrasound measurements and risk of adverse neonatal outcomes in pregnancies complicated by hyperglycaemia: A retrospective study.
fetal macrosomia
gestational diabetes
infant low birth weight
pregnancy in diabetics
ultrasound
Journal
The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
04
09
2020
accepted:
20
10
2020
pubmed:
4
1
2021
medline:
30
6
2021
entrez:
3
1
2021
Statut:
ppublish
Résumé
Antenatal ultrasound is used frequently in pregnancies complicated by hyperglycaemia; however, it is unclear which measurements have the greatest association with adverse neonatal outcomes. To assess the association between third trimester ultrasound parameters with adverse neonatal outcomes in pregnancies complicated by hyperglycaemia. All pregnant women with gestational or type 2 diabetes who birthed in a regional hospital over 12 months were included. A composite adverse neonatal outcome was defined by one or more: admission to special care nursery, acidosis, hypoglycaemia, jaundice, shoulder dystocia, respiratory distress syndrome or 5-minute Apgar score < 5. Logistic regression was used to determine odds ratios (OR) for an adverse neonatal outcome, according to pre-specified cut points in both lower and upper percentiles of abdominal circumference (AC) and estimated fetal weight (EFW). Of 275 births an adverse outcome occurred in 122 (44%). Unadjusted OR (95% CI) for AC ≤30 An AC and EFW up to the 30
Sections du résumé
BACKGROUND
Antenatal ultrasound is used frequently in pregnancies complicated by hyperglycaemia; however, it is unclear which measurements have the greatest association with adverse neonatal outcomes.
AIM
To assess the association between third trimester ultrasound parameters with adverse neonatal outcomes in pregnancies complicated by hyperglycaemia.
METHOD
All pregnant women with gestational or type 2 diabetes who birthed in a regional hospital over 12 months were included. A composite adverse neonatal outcome was defined by one or more: admission to special care nursery, acidosis, hypoglycaemia, jaundice, shoulder dystocia, respiratory distress syndrome or 5-minute Apgar score < 5. Logistic regression was used to determine odds ratios (OR) for an adverse neonatal outcome, according to pre-specified cut points in both lower and upper percentiles of abdominal circumference (AC) and estimated fetal weight (EFW).
RESULTS
Of 275 births an adverse outcome occurred in 122 (44%). Unadjusted OR (95% CI) for AC ≤30
CONCLUSION
An AC and EFW up to the 30
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
366-372Informations de copyright
© 2021 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Références
Meloncelli NJL, Barnett AG, D'Emden M, De Jersey SJ. Effects of changing diagnostic criteria for gestational diabetes mellitus in Queensland, Australia. Obstet Gynecol. 2020; 135(5): 1215-1221.
Chee C, Hibbert EJ, Lam P, et al. Sonographic and other nonglycemic factors can predict large-for-gestational-age infants in diet-managed gestational diabetes mellitus: a retrospective cohort study. J Diabetes. 2020; 12 (8): 562-572.
Nankervis AMH, Moses R, Ross GP et al. ADIPS Consensus Guidelines for the Testing and Diagnosis of Hyperglycaemia in Pregnancy in Australia and New Zealand (modified November 2014), 2014 [cited 2019 February]. Available from URL: https://www.adips.org/information-for-health-care-providers-approved.asp
Rosen H, Shmueli A, Ashwal E et al. Delivery outcomes of large-for-gestational-age newborns stratified by the presence or absence of gestational diabetes mellitus. Int J Gynaecol Obstet. 2018; 141(1): 120-125.
Boulvain M, Senat MV, Perrotin F et al. Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. Lancet 2015; 385(9987): 2600-2605.
Smith-Bindman R, Chu PW, Ecker J et al. Adverse birth outcomes in relation to prenatal sonographic measurements of fetal size. J Ultrasound Med. 2003; 22(4): 347-356; quiz 57-8.
McCowan LM, Figueras F, Anderson NH. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol. 2018; 218(2S): S855-S868.
Hammami A, Mazer Zumaeta A, Syngelaki A, et al. Ultrasonographic estimation of fetal weight: development of new model and assessment of performance of previous models. Ultrasound Obstet Gynecol. 2018; 52(1): 35-43.
Pretscher J, Kehl S, Stumpfe FM et al. Ultrasound fetal weight estimation in diabetic pregnancies. J Ultrasound Med. 2020; 39(2): 341-350.
Araujo Junior E, Peixoto AB, Zamarian AC et al. Macrosomia. Best Pract Res Clin Obstet Gynaecol. 2017; 38: 83-96.
American College of Obstetrician Gynaecologists. ACOG practice bulletin: shoulder dystocia. Number 40, November 2002. Obstet Gynecol. 2002;100(5 Pt 1):1045-1050.
QueenslandHealth. Gestational Diabetes Mellitus 2015 [Maternity and Neonatal Clinical Guideline]. Available from URL: https://www.health.qld.gov.au/qcg/publications.
Bamberg C, Hinkson L, Henrich W. Prenatal detection and consequences of fetal macrosomia. Fetal Diagn Ther. 2013; 33(3): 143-148.
Lausman A, Kingdom J, Maternal Fetal Medicine Committee. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can. 2013; 35(8): 741-748.
Metzger BE, Gabbe SG, Persson B et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33(3): 676-682.
Crowther CA, Hiller JE, Moss JR et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352(24): 2477-2486.
Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology 1991; 181(1): 129-133.
Chitty LS, Altman DG, Henderson A, Campbell S. Charts of fetal size: 3. Abdominal measurements. Br J Obstet Gynaecol. 1994; 101(2): 125-131.
Dobbins TA, Sullivan EA, Roberts CL, Simpson JM. Australian national birthweight percentiles by sex and gestational age, 1998-2007. Med J Aust. 2012; 197(5): 291-294.
Kim M, Park J, Kim SH et al. The trends and risk factors to predict adverse outcomes in gestational diabetes mellitus: a 10-year experience from 2006 to 2015 in a single tertiary center. Obstet Gynecol Sci. 2018; 61(3): 309-318.
Ducarme G, Roure FDD, Le Thuaut AL et al. Efficacy of maternal and biological parameters at the time of diagnosis of gestational diabetes mellitus in predicting neonatal morbidity. Eur J Obstet Gynecol Reprod Biol. 2018; 221: 113-118.
Rowan JA, Hague WM, MiG Trial Investigators. et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008; 358(19): 2003-2005.
MacDonald TM, Hui L, Tong S et al. Reduced growth velocity across the third trimester is associated with placental insufficiency in fetuses born at a normal birthweight: a prospective cohort study. BMC Med. 2017; 15(1): 164.
Zhang J, Kim S, Grewal J, Albert PS. Predicting large fetuses at birth: do multiple ultrasound examinations and longitudinal statistical modelling improve prediction? Paediatr Perinat Epidemiol. 2012; 26(3): 199-207.
Dude AM, Yee LM. Identifying fetal growth disorders using ultrasonography in women with diabetes. J Ultrasound Med. 2018; 37(5): 1103-1108.
Ciobanu A, Khan N, Syngelaki A et al. Routine ultrasound at 32 vs 36 weeks' gestation: prediction of small-for-gestational-age neonates. Ultrasound Obstet Gynecol. 2019; 53(6): 761-8.
Schaefer-Graf UM, Kjos SL et al. Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes. Diabet Med. 2003; 20(5): 349-54.
Kjos SL, Schaefer-Graf UM. Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets. Diabetes Care 2007; 30(Suppl 2): S200-S205.
Aviram A, Yogev Y, Ashwal E et al. Different formulas, different thresholds and different performance-the prediction of macrosomia by ultrasound. J Perinatol. 2017; 37(12): 1285-1291.
Coustan DR, Lowe LP, Metzger BE et al.. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol. 2010;202:654 e1-6.
Kevat DA, Sinha AK, McLean AG. Lower treatment targets for gestational diabetes: is lower really better? Med J Aust. 2014; 201(4): 204-7.